Literature DB >> 11418670

A distinct pathway of cell-mediated apoptosis initiated by granulysin.

A A Kaspar1, S Okada, J Kumar, F R Poulain, K A Drouvalakis, A Kelekar, D A Hanson, R M Kluck, Y Hitoshi, D E Johnson, C J Froelich, C B Thompson, D D Newmeyer, A Anel, C Clayberger, A M Krensky.   

Abstract

Granulysin is an antimicrobial and tumoricidal molecule expressed in granules of CTL and NK cells. In this study, we show that granulysin damages cell membranes based upon negative charge, disrupts the transmembrane potential (Deltapsi) in mitochondria, and causes release of cytochrome c. Granulysin-induced apoptosis is blocked in cells overexpressing Bcl-2. Despite the release of cytochrome c, procaspase 9 is not processed. Nevertheless, activation of caspase 3 is observed in granulysin-treated cells, suggesting that granulysin activates a novel pathway of CTL- and NK cell-mediated death distinct from granzyme- and death receptor-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11418670     DOI: 10.4049/jimmunol.167.1.350

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Opposing roles of activator protein-1 and CCAAT/enhancer binding protein beta in the regulation of inducible granulysin gene expression in a human monocytic cell line, THP-1.

Authors:  Yutaka Kida; Takashi Shimizu; Koichi Kuwano
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

Review 2.  Effector lymphocytes in islet cell autoimmunity.

Authors:  Pere Santamaria
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

3.  Analysis of granulysin-mediated cytotoxicity in peripheral blood of patients with psoriatic arthritis.

Authors:  Drazen Massari; Larisa Prpic-Massari; Tatjana Kehler; Marija Kastelan; Bozidar Curkovic; Viktor Persic; Alen Ruzic; Gordana Laskarin
Journal:  Rheumatol Int       Date:  2011-08-10       Impact factor: 2.631

4.  In vivo potential of recombinant granulysin against human tumors.

Authors:  Sameer Al-Wasaby; Diego de Miguel; Adriana Aporta; Javier Naval; Blanca Conde; Luis Martínez-Lostao; Alberto Anel
Journal:  Oncoimmunology       Date:  2015-07-01       Impact factor: 8.110

5.  Plasma granulysin concentrations and preeclampsia risk.

Authors:  Chunfang Qiu; Shigeru Saito; Masatoshi Sakai; Kazuyuki Ogawa; Kinya Nagata; Michelle A Williams
Journal:  Clin Biochem       Date:  2006-08-16       Impact factor: 3.281

6.  Hemolysis of erythrocytes by granulysin-derived peptides but not by granulysin.

Authors:  Qing Li; Chen Dong; Anmei Deng; Masao Katsumata; Ari Nakadai; Tomoyuki Kawada; Satoshi Okada; Carol Clayberger; Alan M Krensky
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

7.  Cholesterol in negatively charged lipid bilayers modulates the effect of the antimicrobial protein granulysin.

Authors:  Hanna Barman; Michael Walch; Sonja Latinovic-Golic; Claudia Dumrese; Max Dolder; Peter Groscurth; Urs Ziegler
Journal:  J Membr Biol       Date:  2007-01-06       Impact factor: 1.843

Review 8.  A short guided tour through functional and structural features of saposin-like proteins.

Authors:  Heike Bruhn
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

Review 9.  Transcriptional control of mitochondrial biogenesis and its interface with inflammatory processes.

Authors:  Claude A Piantadosi; Hagir B Suliman
Journal:  Biochim Biophys Acta       Date:  2012-01-14

10.  Increased granulysin expression in peripheral blood cells of patients with primary biliary cirrhosis and its clinical implications.

Authors:  Cheng Qian; Sunxiao Chen; Dingkang Yao; Chuanyong Wu; Tingwang Jiang; Jinshan Ke; Ye Zhou; Mingli Gu; Bo Chen; Anmei Deng; Renqian Zhong
Journal:  J Clin Immunol       Date:  2008-06-28       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.